SCHEMBL23187464

SCHEMBL23187464

O=C(CCCCl)NC1CN(C(=O)OCc2ccccc2)C1

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 5/20 0.52
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
CHRM4 P08173 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
CYP2C19 P33261 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
EPHX2 P34913 1/20 0.44
GRIN2B Q13224 2/20 0.44
EPHX1 P07099 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6962965 0.88 ENPP2 (0.66) ENPP2SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL4875063 0.85 ENPP2 (0.67) ENPP2SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL18032530 0.79 ENPP2 (0.58) ENPP2SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL13521537 0.79 MEN1 (0.57) ENPP2SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL10304113 0.77 MEN1 (0.58) MEN1KMT2AEPHX2EPHX1ALDH1A1
SCHEMBL28333058 0.77 MEN1 (0.58) MEN1KMT2AEPHX2EPHX1ALDH1A1
SCHEMBL6975151 0.77 KMT2A (0.67) ENPP2SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL31481320 0.77 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9ACHRM4MEN1
SCHEMBL20771790 0.77 CHRM4 (0.52) SMN1; SMN2NPC1RAB9ACHRM4MEN1
SCHEMBL14428335 0.75 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ACHRM4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021064077-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES AS IRAK4 INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2021-04-08 WO disclosed
EP-3800188-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES AS IRAK4 INHIBITORS Bayer AG (DE) 2021-04-07 EP disclosed
EP-3800188-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES AS IRAK4 INHIBITORS Bayer AG (DE) 2021-04-07 EP disclosed